The American journal of gastroenterology
Long-term effectiveness of tenofovir alafenamide versus entecavir in treatment-naïve chronic hepatitis B: A REAL-B study.
Jie Li, Joanne Kimiko Liu, Angela Chau, Sovann Linden, Pei-Chien Tsai, Akito Nozaki, Philip Vutien, Haruki Uojima, Hidenori Toyoda, Takashi Honda, Huy Trinh, Hiroshi Abe, Toru Ishikawa, Masanori Atsukawa, Tsunamasa Watanabe
Published: 202510.14309/ajg.0000000000003881
Abstract
BACKGROUND AIMS: While both tenofovir alafenamide (TAF) and entecavir (ETV) are recommended first-line treatments for chronic hepatitis B (CHB), comparative data on their effectiveness remain limited. We aim to compare their virologic (VR), biochemic…
Preview only. Read the full abstract at the source